- Adult Stem Cell
- Human Embryonic Cell
- Pluripotent Stem Cell
- Others
Stem Cells Market size was valued at USD 17.12 billion by 2023 and is poised to grow at a CAGR of 8.6% from 2024 - 2030. owing to increase in prevalence of target chronic diseases and higher adoption of technological advancements coupled with rise in the economy and per capita expenditure are expected to drive the growth of the market. Moreover, rising investments in R&D owing to increased demand for stem cell production for potential investigation in disease management and cellular therapies are also recognized as the next major advancements in transforming healthcare. Additionally, Market players are expanding their cellular therapy portfolio understanding the future potential of the segment which fuels the growth of the market. However, expensive procedures for the development of stem cell therapies and regulatory complications restrain the growth of the market. Global stem cell market is surging due to increased approvals and strategic collaborations among the market players to strengthen their position different regions of the globe. For instance,
Stem Cells Market Key Developments:
- In April 2018, Pluristem Therapeutics Inc., a developer of placenta-based stem cell products announced that the U.S.FDA has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.
- In September 2017, Pluristem Therapeutics Inc. announced that the company has issued two new patients by Hong Kong Patents Registry for its cell therapy products relating to two of the company's leading indications, Critical Limb Ischemia (CLI) and muscle regeneration.
Global Stem Cells Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
8.6%
Largest Market
North America
Fastest Growing Market
Europe
Stem Cells Market Dynamics
Scientists are involved in discovering novel methods in creating human stem cells owing to rising demand for the stem cell production. For instance, in March 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells from a cellular trash pile. These novel discoveries in stem cell therapies are recognized as the major advancements in the transformation of healthcare. Support of the government in discovering stem cells and the increase in number of stem cell banks are expected to fuel the growth of the market.
North-America Got Significant Share
Stem Cells Market Regional Analysis
North America accounted for a larger revenue share in the global stem cells market with significant CAGR owing to increase in approvals for clinical trials in stem cell research. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. High investments on R&D and increasing demand for regenerative treatment options drives the growth of the market over the forecast period. Europe is expected to grow at highest CAGR owing to increasing disposable income and the development of infrastructure encourages the growth of the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Stem Cells Market Segmentation
By Product Type
By Application Type
- Regenerative Medicine
- Drug Discovery and Development
By Therapy Area
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Therapy
- Syngeneic Stem Cell Therapy
By Technology Type
- Cell Acquisition
- Cell Production
- Cryopreservation
- Expansion and Sub-Culture
Frequently Asked Questions
The stem cells market size was valued at USD 17.12 billion in 2023
The stem cells market key players are: Osiris Therapeutics Inc. Pluristem Therapeutics Inc. Celgene Corporation Thermo Fisher Scientific Qiagen NV Miltenyi Biotec Advanaced Cell Technology Inc. Sigma Aldrich Corporation Stem Cell Technologies Inc. Becton, Dickinson and Company AllCells LLC International Stem Cell Corporation
The stem cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Stem Cells Market Introduction |
| 2.1.Global Stem Cells Market - Taxonomy |
| 2.2.Global Stem Cells Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application Type |
| 2.2.3.Therapy Area |
| 2.2.4.Technology Type |
| 2.2.5.Region |
| 3. Global Stem Cells Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Stem Cells Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Stem Cells Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Adult Stem Cell |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Human Embryonic Cell |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Pluripotent Stem Cell |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Stem Cells Market By Application Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Regenerative Medicine |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Drug Discovery and Development |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Stem Cells Market By Therapy Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Autologous Stem Cell Therapy |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Allogeneic Stem Cell Therapy |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Syngeneic Stem Cell Therapy |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Stem Cells Market By Technology Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Cell Acquisition |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Cell Production |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Cryopreservation |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Expansion and Sub-Culture |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Stem Cells Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Adult Stem Cell |
| 10.1.2.Human Embryonic Cell |
| 10.1.3.Pluripotent Stem Cell |
| 10.1.4.Others |
| 10.2. Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Regenerative Medicine |
| 10.2.2.Drug Discovery and Development |
| 10.3. Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Autologous Stem Cell Therapy |
| 10.3.2.Allogeneic Stem Cell Therapy |
| 10.3.3.Syngeneic Stem Cell Therapy |
| 10.4. Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Cell Acquisition |
| 10.4.2.Cell Production |
| 10.4.3.Cryopreservation |
| 10.4.4.Expansion and Sub-Culture |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Adult Stem Cell |
| 11.1.2.Human Embryonic Cell |
| 11.1.3.Pluripotent Stem Cell |
| 11.1.4.Others |
| 11.2. Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Regenerative Medicine |
| 11.2.2.Drug Discovery and Development |
| 11.3. Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Autologous Stem Cell Therapy |
| 11.3.2.Allogeneic Stem Cell Therapy |
| 11.3.3.Syngeneic Stem Cell Therapy |
| 11.4. Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Cell Acquisition |
| 11.4.2.Cell Production |
| 11.4.3.Cryopreservation |
| 11.4.4.Expansion and Sub-Culture |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Adult Stem Cell |
| 12.1.2.Human Embryonic Cell |
| 12.1.3.Pluripotent Stem Cell |
| 12.1.4.Others |
| 12.2. Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Regenerative Medicine |
| 12.2.2.Drug Discovery and Development |
| 12.3. Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Autologous Stem Cell Therapy |
| 12.3.2.Allogeneic Stem Cell Therapy |
| 12.3.3.Syngeneic Stem Cell Therapy |
| 12.4. Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Cell Acquisition |
| 12.4.2.Cell Production |
| 12.4.3.Cryopreservation |
| 12.4.4.Expansion and Sub-Culture |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Adult Stem Cell |
| 13.1.2.Human Embryonic Cell |
| 13.1.3.Pluripotent Stem Cell |
| 13.1.4.Others |
| 13.2. Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Regenerative Medicine |
| 13.2.2.Drug Discovery and Development |
| 13.3. Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Autologous Stem Cell Therapy |
| 13.3.2.Allogeneic Stem Cell Therapy |
| 13.3.3.Syngeneic Stem Cell Therapy |
| 13.4. Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Cell Acquisition |
| 13.4.2.Cell Production |
| 13.4.3.Cryopreservation |
| 13.4.4.Expansion and Sub-Culture |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Adult Stem Cell |
| 14.1.2.Human Embryonic Cell |
| 14.1.3.Pluripotent Stem Cell |
| 14.1.4.Others |
| 14.2. Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Regenerative Medicine |
| 14.2.2.Drug Discovery and Development |
| 14.3. Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Autologous Stem Cell Therapy |
| 14.3.2.Allogeneic Stem Cell Therapy |
| 14.3.3.Syngeneic Stem Cell Therapy |
| 14.4. Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Cell Acquisition |
| 14.4.2.Cell Production |
| 14.4.3.Cryopreservation |
| 14.4.4.Expansion and Sub-Culture |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Osiris Therapeutics Inc. |
| 15.2.2.Pluristem Therapeutics Inc. |
| 15.2.3.Celgene Corporation |
| 15.2.4.Thermo Fisher Scientific |
| 15.2.5.Qiagen NV |
| 15.2.6.Miltenyi Biotec |
| 15.2.7.Advanaced Cell Technology Inc. |
| 15.2.8.Sigma Aldrich Corporation |
| 15.2.9 Stem Cell Technologies Inc. |
| 15.2.10.Becton, Dickinson and Company |
| 15.2.11.AllCells LLC |
| 15.2.12.International Stem Cell Corporation |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Osiris Therapeutics Inc.
- Pluristem Therapeutics Inc.
- Celgene Corporation
- Thermo Fisher Scientific
- Qiagen NV
- Miltenyi Biotec
- Advanaced Cell Technology Inc.
- Sigma Aldrich Corporation
- Stem Cell Technologies Inc.
- Becton, Dickinson and Company
- AllCells LLC
- International Stem Cell Corporation